Clinical Trial Update: Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update examining cognitive effects of adjuvant vortioxetine in early schizophrenia is ongoing, with unspecified status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment in Schizophrenia
• Negative Symptoms in Schizophrenia
• Schizophrenia

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Cognitive Impairment With Primary Psychotic Disorder, Negative Symptoms With Primary Psychotic Disorder | Phase 2, Phase 3 | Status: UNKNOWN